D. Boral Capital analyst Jason Kolbert maintains Marinus Pharma (NASDAQ:MRNS) with a Buy and maintains $3 price target.
- Headlines
- D. Boral Capital Maintains Buy on Marinus Pharma, Maintains $3 Price Target
D. Boral Capital Maintains Buy on Marinus Pharma, Maintains $3 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
23:52
Japanese media: Shigeru Ishiba and Volodymyr Zelensky had their first phone call.
23:40
Xinhua News Agency reported: On the 25th, the Ministry of Emergency Situations of Kazakhstan confirmed that 38 people died in the plane crash.
23:35
The Ministry of Emergency Situations of Kazakhstan: 29 people are hospitalized for treatment following the plane crash.